UBS Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-197,500
Closed -$18.8M 8585
2018
Q3
$18.8M Buy
197,500
+97,500
+98% +$8.31M 0.01% 1255
2018
Q2
$7.72M Buy
100,000
+30,000
+43% +$2.25M ﹤0.01% 1953
2018
Q1
$4.84M Buy
+70,000
New +$5.34M ﹤0.01% 2348
2017
Q2
Sell
-500
Closed -$33K 8228
2017
Q1
$33K Sell
500
-130,223
-100% -$8.96M ﹤0.01% 5802
2016
Q4
$8.99M Sell
130,723
-64,070
-33% -$4.59M 0.01% 1586
2016
Q3
$13.7M Buy
194,793
+181,000
+1,312% +$13.5M 0.01% 1193
2016
Q2
$1.05M Buy
13,793
+12,793
+1,279% +$941K ﹤0.01% 3343
2016
Q1
$69K Sell
1,000
-10,311
-91% -$741K ﹤0.01% 5253
2015
Q4
$989K Sell
11,311
-92,922
-89% -$7.96M ﹤0.01% 3415
2015
Q3
$8.44M Buy
104,233
+89,200
+593% +$7.77M 0.01% 1523
2015
Q2
$1.34M Sell
15,033
-63,342
-81% -$5.53M ﹤0.01% 3340
2015
Q1
$6.8M Buy
78,375
+58,200
+288% +$4.88M ﹤0.01% 1797
2014
Q4
$1.71M Buy
+20,175
New +$1.58M ﹤0.01% 3053

Other funds holding ESRX

UBS Group's ESRX Position: Q4 2018 in Review

UBS Group sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 1,689,763 shares — an estimated $161M sold.

UBS Group first reported a position in ESRX in Q4 2014 and held it in 16 quarters. The position peaked at $277M in Q4 2014. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • UBS Group reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • UBS Group sold 1,689,763 Express Scripts Holding Company shares in Q4 2018, an estimated $161M.
  • UBS Group first reported a position in Express Scripts Holding Company in Q4 2014 and held it in 16 quarters.
  • UBS Group's Express Scripts Holding Company position peaked at $277M in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.